Anup K Kasi Loknath Kumar

Trials

Studies that name Anup K Kasi Loknath Kumar as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:34 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT07619521 · Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma

  National Cancer Institute (NCI) · recruiting · Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 · principal investigator
• Ph2
  NCT06178588 · Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma

  University of Kansas Medical Center · active not recruiting · Locally Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Recurrent Cholangiocarcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Supplement to Extend Funds for Grant #UM1CA186689 VICKtOrY Early Clinical Trials Consortium
  UM1CA186689 · NCI · YALE UNIVERSITY · PI Patricia M. LoRusso · fiscal years 2014 to 2026
  Named on NCT07619521
• Shared Resources Management
  P30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Matthew S Mayo · fiscal years 2012 to 2026
  Named on NCT06178588